1. Home
  2. TFFP
  3. TFFP News

Latest TFF Pharmaceuticals Inc. (TFFP) News on November 18, 2024

TFFP

MT Newswires

3 days ago

Top Midday Decliners

TFFP

MT Newswires

3 days ago

Sector Update: Health Care Stocks Decline Premarket Friday

TFFP

MT Newswires

3 days ago

TFF Pharmaceuticals Shares Slump After Board Approves Dissolution

TFFP

MT Newswires

3 days ago

Top Premarket Decliners

TFFP

GlobeNewswire

4 days ago

TFF Pharmaceuticals Announces It Will Wind Down Operations

TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why
TFFP

Zacks

a month ago

TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why

TFFP

MT Newswires

2 months ago

Top Premarket Decliners

TFFP

GlobeNewswire

2 months ago

TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery

TFFP

MT Newswires

2 months ago

TFF Pharmaceuticals Partners With Emory University, BARDA to Powderize Antiviral Drug

TFFP

GlobeNewswire

2 months ago

TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

TFFP

GlobeNewswire

2 months ago

TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

TFFP

GlobeNewswire

2 months ago

TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

TFF Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
TFFP

Simply Wall St.

3 months ago

TFF Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations

TFF Pharmaceuticals, Inc. (TFFP) Reports Q2 Loss, Tops Revenue Estimates
TFFP

Zacks

3 months ago

TFF Pharmaceuticals, Inc. (TFFP) Reports Q2 Loss, Tops Revenue Estimates

TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
TFFP

GlobeNewswire

3 months ago

TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
TFFP

GlobeNewswire

3 months ago

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities
TFFP

GlobeNewswire

5 months ago

TFF Pharmaceuticals Engages Outcome Capital As a Strategic Advisor for Evaluating Partnership and Licensing Opportunities

TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection
TFFP

GlobeNewswire

5 months ago

TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF TAC) Clinical Program for the Prevention of Lung Transplant Rejection

TFFP

MT Newswires

6 months ago

TFF Pharmaceuticals, Leidos to Advance Biodefense Countermeasures Into Preclinical Testing

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
TFFP

GlobeNewswire

6 months ago

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

TFFP

MT Newswires

6 months ago

TFF Pharmaceuticals Advances Influenza Vaccine Candidates Into Preclinical Testing

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
TFFP

GlobeNewswire

6 months ago

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
TFFP

GlobeNewswire

6 months ago

TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates
TFFP

Zacks

6 months ago

TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
TFFP

GlobeNewswire

6 months ago

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
TFFP

GlobeNewswire

7 months ago

TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering

TFFP

MT Newswires

7 months ago

TFF Pharmaceuticals Prices $4.8 Million Public Offering; Shares Down Pre-Bell

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
TFFP

GlobeNewswire

7 months ago

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting
TFFP

GlobeNewswire

7 months ago

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
TFFP

GlobeNewswire

7 months ago

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions

TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations
TFFP

Simply Wall St.

8 months ago

TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TFF Pharmaceuticals Announces Update on Clinical Programs
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals Announces Update on Clinical Programs

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
TFFP

GlobeNewswire

8 months ago

TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024

Gold Resource Corporation Announces Preliminary Fourth Quarter and Year-End Results
TFFP

Business Wire

10 months ago

Gold Resource Corporation Announces Preliminary Fourth Quarter and Year-End Results

Is GigaCloud Technology Inc. (GCT) Outperforming Other Business Services Stocks This Year?
TFFP

Zacks

10 months ago

Is GigaCloud Technology Inc. (GCT) Outperforming Other Business Services Stocks This Year?

Here's Why Momentum in EuroDry (EDRY) Should Keep going
TFFP

Zacks

10 months ago

Here's Why Momentum in EuroDry (EDRY) Should Keep going

Space Race Speculation: 3 Stocks Soaring in the New Frontier
TFFP

InvestorPlace

10 months ago

Space Race Speculation: 3 Stocks Soaring in the New Frontier

TFFP

Associated Press Finance

10 months ago

Bassett: Fiscal Q4 Earnings Snapshot

Bassett Announces Fiscal Fourth Quarter Results
TFFP

GlobeNewswire

10 months ago

Bassett Announces Fiscal Fourth Quarter Results

FAT Brands (FAT) Reports Solid Unit Developments in 2023
TFFP

Zacks

10 months ago

FAT Brands (FAT) Reports Solid Unit Developments in 2023

MoneyHero Group Preannounces Record Breaking Year-Over-Year Growth, Outshining Competitors
TFFP

GlobeNewswire

10 months ago

MoneyHero Group Preannounces Record Breaking Year-Over-Year Growth, Outshining Competitors

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference
TFFP

GlobeNewswire

10 months ago

TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference

Alliance Entertainment to Host Fiscal Second Quarter 2024 Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time
TFFP

GlobeNewswire

10 months ago

Alliance Entertainment to Host Fiscal Second Quarter 2024 Results Conference Call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time

Nauticus Robotics Secures Additional Funding, Appoints New Executive Management, Improves Operations and Cost Structures, and Engages Strategic Advisor
TFFP

PR Newswire

10 months ago

Nauticus Robotics Secures Additional Funding, Appoints New Executive Management, Improves Operations and Cost Structures, and Engages Strategic Advisor

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
TFFP

GlobeNewswire

10 months ago

TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting

Via Renewables, Inc. Enters into Agreement for all of Its Class A Common Stock to be Acquired at $11.00 Per Share in Cash
TFFP

ACCESSWIRE

a year ago

Via Renewables, Inc. Enters into Agreement for all of Its Class A Common Stock to be Acquired at $11.00 Per Share in Cash

Here's Why Electrameccanica Vehicles (NASDAQ:SOLO) Must Use Its Cash Wisely
TFFP

Simply Wall St.

a year ago

Here's Why Electrameccanica Vehicles (NASDAQ:SOLO) Must Use Its Cash Wisely

CMCT Declares Common Stock Dividend
TFFP

Business Wire

a year ago

CMCT Declares Common Stock Dividend

TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC
TFFP

GlobeNewswire

a year ago

TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TAC

TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC
TFFP

GlobeNewswire

a year ago

TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC

MDV or ESS: Which Is the Better Value Stock Right Now?
TFFP

Zacks

a year ago

MDV or ESS: Which Is the Better Value Stock Right Now?

TFF Pharmaceuticals Announces Reverse Stock Split
TFFP

GlobeNewswire

a year ago

TFF Pharmaceuticals Announces Reverse Stock Split

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
TFFP

GlobeNewswire

a year ago

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
TFFP

GlobeNewswire

a year ago

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022
TFFP

Business Wire

a year ago

Vertex Energy Meets Renewable Fuel Standard Revised Annual Compliance Report Filing Deadline of December 1, 2023, for Calendar Year 2022

Annovis Bio Appoints Andrew Walsh as Vice President Finance
TFFP

GlobeNewswire

a year ago

Annovis Bio Appoints Andrew Walsh as Vice President Finance

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors
TFFP

GlobeNewswire

a year ago

TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors

TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
TFFP

GlobeNewswire

a year ago

TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
TFFP

ACCESSWIRE

a year ago

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

7 Penny Stocks With Low Floats and High Short Interest
TFFP

InvestorPlace

a year ago

7 Penny Stocks With Low Floats and High Short Interest

eHealth, Inc. Announces Senior Leadership Changes and Reaffirms Full Year Fiscal 2023 Guidance
TFFP

PR Newswire

a year ago

eHealth, Inc. Announces Senior Leadership Changes and Reaffirms Full Year Fiscal 2023 Guidance

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
TFFP

GlobeNewswire

a year ago

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

TFFP

Business Wire

a year ago

Intevac Announces Participation in 12th Annual NYC Summit

Willamette Valley Vineyards Posts results for Q3 2023
TFFP

PR Newswire

a year ago

Willamette Valley Vineyards Posts results for Q3 2023

Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended September 30, 2023
TFFP

GlobeNewswire

a year ago

Professional Diversity Network, Inc. Announces Financial Results for the Quarter Ended September 30, 2023

TFFP

Associated Press Finance

a year ago

Reading International: Q3 Earnings Snapshot

Reading International Reports Third Quarter 2023 Results
TFFP

GlobeNewswire

a year ago

Reading International Reports Third Quarter 2023 Results

Air T, Inc. Reports Second Quarter Fiscal 2024 Results
TFFP

ACCESSWIRE

a year ago

Air T, Inc. Reports Second Quarter Fiscal 2024 Results

U.S. Energy Corp. Reports Financial and Operating Results for Third Quarter 2023
TFFP

GlobeNewswire

a year ago

U.S. Energy Corp. Reports Financial and Operating Results for Third Quarter 2023

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript
TFFP

Insider Monkey

a year ago

ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript

PLBY Group Reports Third Quarter 2023 Financial Results
TFFP

GlobeNewswire

a year ago

PLBY Group Reports Third Quarter 2023 Financial Results

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
TFFP

GlobeNewswire

a year ago

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
TFFP

GlobeNewswire

a year ago

Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results

TFFP

Thomson Reuters StreetEvents

a year ago

Q3 2023 Fossil Group Inc Earnings Call

Intevac (NASDAQ:IVAC) investors are sitting on a loss of 40% if they invested three years ago
TFFP

Simply Wall St.

a year ago

Intevac (NASDAQ:IVAC) investors are sitting on a loss of 40% if they invested three years ago

TFFP

Associated Press Finance

a year ago

Fossil Group: Q3 Earnings Snapshot

Fossil Group, Inc. Reports Third Quarter 2023 Financial Results
TFFP

GlobeNewswire

a year ago

Fossil Group, Inc. Reports Third Quarter 2023 Financial Results

InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript
TFFP

Insider Monkey

a year ago

InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System
TFFP

GlobeNewswire

a year ago

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

TFFP

Thomson Reuters StreetEvents

a year ago

Q3 2023 Beasley Broadcast Group Inc Earnings Call

Beasley Broadcast Group (BBGI) Surpasses Q3 Earnings Estimates
TFFP

Zacks

a year ago

Beasley Broadcast Group (BBGI) Surpasses Q3 Earnings Estimates

Share on Social Networks: